| REGENERON PHARMAC.DL-,001 |
| USA |
| Gesundheit |
| US75886F1075 / 881535 |
| RGO (Frankfurt) / REGN (NASDAQ) |
| FRA:RGO, ETR:RGO, RGO:GR, NASDAQ:REGN |
| http://www.regeneron.com/ |
|
Regeneron Pharmaceuticals, Inc. is a biotechnology company focused on the discovery, development, manufacturing, and commercialization of innovative medicines that address serious medical conditions. ..
>Volltext.. |
| 71752.5 Mio. EUR |
| 66945 Mio. EUR |
| 12122.18 Mio. EUR |
| 3588.33 Mio. EUR |
| 3807.4 Mio. EUR |
| 36.44 EUR |
| 2512.43 Mio. EUR |
| 2640.06 Mio. EUR |
| 4208.01 Mio. EUR |
| 1.97 |
| -10.98% |
| -10.02% |
| 3.24 EUR |
| 0.44% |
| 0.47% |
| 20.11.25 - 0.76287204€ 18.08.25 - 0.75152€ >weitere anzeigen... |
| REGENERON |
| 20.02.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|